This site is intended for Healthcare professionals only.
×

NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details


NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 18 drug formulations under the Drugs Prices Control Order (DPCO), 2013 exclusive of goods and services tax (GST).

The medicines whose price have been fixed by NPPA include painkiller, medicine for lowering cholesterol and fats, diabetes drugs and others. The list also includes various fixed-dose combination in capsule, tablets and injection dosage form in different strength.

The drug formulations whose price has recently been fixed by NPPA include Voveran 1ml AQ Injection, combinations of Diclofenac + Thiocolchicoside Capsule; Glimepiride + Metformin + Voglibose Tablet; Metformin + Glimepiride Tablet and others sold under different brand names.

Notable drug makers inclusive of Novartis India, Zydus Healthcare, Akums Drugs, Inventia Healthcare and others are responsible for the manufacture of the formulations.

Many FDC whose price has been fixed are commonly used. For instance, Atorvastatin Tablet is used along with a proper diet to help lower “bad” cholesterol and fats (such as LDL, triglycerides) and raise “good” cholesterol (HDL) in the blood. It belongs to a group of drugs known as “statins.” It works by reducing the amount of cholesterol made by the liver.

Lowering “bad” cholesterol and triglycerides and raising “good” cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks.

While another combination of Glimepiride + Metformin + Voglibose Tablet sold under brand name Glycomet-TRIO manufactured by Sanofi is indicated for treating diabetes while a combination of Metformin + Voglibose Tablet, manufactured by Cipla is sold under brand name Prandial-M is used to control high blood glucose levels in patients with type 2 diabetes mellitus.

The detail of the medicines issued by NPPA reads;

Sl.

No.

Name of the Formulation /

Brand Name

Strength Unit Manufacturer & Marketing Company Retail Price

(Rs.)

(1) (2) (3) (4) (5) (6)
1. Alpha Lipoic + Methylcobalamin + Inositol USP + Folic Acid + Benfotiamine + Chromium Polynicotinate + Pyridoxine

Hydrochloride Capsule

Each soft gelatine capsule contains: Alpha Lipoic Acid USP 200 mg, Methylcobalamin 1500 mcg,

Inositol USP NF 100 mg, Folic Acid IP 1.5mg, Benfotiamine 150 mg, Chromium Polynicotinate 200 mcg, Pyridoxine Hydrochloride IP 3 mg

 

 

 

1

Capsule

M/s Olive Healthcare / M/s Zydus Healthcare Limited 15.66
2. Voveran 1ml AQ Injection Each 1ml glass ampoule contains: Diclofenac Sodium IP 75mg, Water for Injection Per 1ml Pack M/s Nitin Life Sciences / M/s Novartis India Limited 21.92
3. Diclofenac + Thiocolchicoside Capsule Each Hard Gelatin capsule contains: Diclofenac Sodium IP 50mg (As Enteric coated tablet)

Thiocolchicoside 4mg

 

1

Capsule

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Novartis India

Limited

12.61
4. Diclofenac + Thiocolchicoside Capsule Each Hard Gelatin capsule contains: Diclofenac Sodium IP 50mg (As Enteric coated tablet)

Thiocolchicoside 8mg

 

1

Capsule

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Novartis India

Limited

18.91
5. Amoxycillin + Clavulanic Acid Tablet (UNIMOX CV 1000) Each film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 875mg,

Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg

 

 

1 Tablet

M/s Theon Pharmaceuticals Ltd. / M/s Macmillon Pharmaceuticals Limited 30.75
6. Glimepiride + Metformin + Voglibose Tablet Each uncoated bilayered tablet contains: Glimepiride IP 2mg,

Metformin Hydrochloride IP 500mg (As Sustained Release form),

Voglibose IP 0.2mg

 

 

1 Tablet

M/s Theon Pharmaceuticals Limited

/ M/s Indoco Remedies Limited

11.80
7. Erythropoietin + Human Albumin + Sodium Chloride +

Sodium Phosphate +

Sodium Dihydrogen Phosphate Monohydrate Injection (Repoitin

40000)

Each 1.0ml contains:

Erythropoietin Concentrated Solution IP 40000IU

Human Albumin IP 2.50mg,

Sodium Chloride IP 7.80mg, Sodium Phosphate IP 2.20mg Sodium Dihydrogen Phosphate Monohydrate B. P. 0.96mg

Water for Injection IP q.s.

 

Per Vial

 

M/s Serum Institute of India Pvt. Ltd.

6490.00
8. Amlodipine + Metoprolol Tablet (Amlosafe MT 25mg) Each film coated bilayered Tablet contains:

Amlodipine Besilate eq. to Amlodipine 5mg,

Metoprolol Succinate 23.75mg eq. to Metoprolol Tartrate 25mg (As Prolonged

Release)

 

 

1 Tablet

 

M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.

5.51
9. Rabeprazole + Domperidone Capsule (Instek D Capsule) Each capsule contains:

Rabeprazole Sodium IP 20mg (as enteric coated pellets),

Domperidone IP 30mg (as sustained release pellets)

 

1

Capsule

 

M/s Inventia Healthcare Limited

8.24
10. Pantoprazole + Domperidone Capsule (Domelong P Capsule) Each hard gelatin capsule contains: Pantoprazole Sodium IP (as Pantoprazole Sodium Sesquihydrate) eq. to Pantoprazole 40mg (as Gastro-resistant pellets)

Domperidone IP 30mg (as Prolonged release pellets)

 

 

1

Capsule

 

 

M/s Inventia Healthcare Limited

8.007
11. Metformin + Voglibose Tablet (Proglutrol V 0.2) Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (in Sustained release form),

Voglibose IP 0.2mg

 

1 Tablet

M/s Inventia Healthcare Pvt. Ltd. 6.76
12. Metformin + Voglibose Tablet (Proglutrol V 0.3) Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (in Sustained release form),

Voglibose IP 0.3mg

 

1 Tablet

M/s Inventia Healthcare Pvt. Ltd. 8.56
13. Metformin + Glimepiride Tablet (Proglutrol G1) Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (in prolonged release form),

Glimepiride IP 1mg

 

1 Tablet

M/s Inventia Healthcare Pvt. Ltd. 5.13
14. Metformin + Glimepiride Tablet (Proglutrol G2) Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500mg (in prolonged release form),

Glimepiride IP 2mg

 

1 Tablet

M/s Inventia Healthcare Pvt. Ltd. 6.76
15. Metformin + Glimepiride Tablet (Proglutrol G1 Forte) Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (in prolonged release form),

Glimepiride IP 1mg

 

1 Tablet

M/s Inventia Healthcare Pvt. Ltd. 6.47
16. Metformin + Glimepiride Tablet (Proglutrol G2 Forte) Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (in prolonged release form),

Glimepiride IP 2mg

 

1 Tablet

M/s Inventia Healthcare Pvt. Ltd. 8.75
17. Pantoprazole Sodium

+

Itopride Hydrochloride Capsules (PANZO-IT)

Each hard gelatine capsules contains: Pantoprazole Sodium IP eq. to Pantoprazole 40mg (as enteric coated pellets),

Itopride Hydrochloride 150mg (as sustained release pellets)

 

 

1

Capsule

M/s Vidhyasha Pharmaceuticals / M/s Macmillon Pharmaceuticals Limited 16.72
18. Atorvastatin Tablet (TORVASON -80) Each film coated tablet contains: Atorvastatin Calcium IP eq. to

Atorvastatin 80mg

 

1 Tablet

M/s Unison Pharmaceuticals Pvt. Ltd. 27.54

The NPPA notice further reads;

  • The manufacturer of above-mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table
  • The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said
  • The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and
  • As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the
  • The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing
  • In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act,
  • Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s)

Also Read: NPPA fixes retail price of 20 drugs including FDCs for Blood pressure control, dual antiplatelet

Spread the love


Source: self
0 comment(s) on NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted